IPO Allotment of Sopan Pharmaceuticals Concluded [IPO Result !!]
April 30, 2026 | Investopaper
IPO Allotment Of Sopan Pharmaceuticals Limited
NMB Capital Limited, the issue manager for the initial public offering (IPO) of Sopan Pharmaceuticals Limited, has concluded the IPO allotment process on Thursday.
After the allotment, 3,47,490 applicants have received 10 shares each through lottery.
A total of 27,30,987 valid applicants had subscribed for the shares. With the allotment, more than 23.8 lakh applicants were left empty-handed.
To view the IPO result of Sopan Pharmaceuticals Limited, click the link below:
IPO Result Of Sopan Pharmaceuticals Limited
Second Phase: IPO To General Public
After the first phase, Sopan Pharmaceuticals Limited had issued the shares to the general public in the second phase of an initial public offering (IPO). The IPO to general public was open from Baisakh 3, 2083 BS.
The company had sold 34,74,900 shares at Rs. 100 per share to the general public.
Interested investors could apply for a minimum of 10 shares and a maximum of 11,000 shares.
The public offering was closed on Baisakh 8, 2083 BS.
The company has allotted 2,14,500 shares to the mutual fund schemes and has reserved 171,600 shares to the employees of the company.
In total (including the first and second phase), the company issued 42.90 lakh shares to the public. This is 25 percent of the total issued capital of the company.
First Phase: IPO To Foreign Employed Nepalis
In the first phase of the IPO, the company had sold the shares to the Nepalis in foreign employment from Chaitra 9, 2082 BS..
The company had issued 4,29,000 shares (10 percent of general public’s quota) to the foreign employed Nepalis. The IPO to foreign employed Nepalis was closed on Chaitra 12, 2082 BS. Interested foreign employed Nepalis could apply for a minimum of 10 shares and a maximum of 11,000 shares.
Securities Board Of Nepal (SEBON) gave the permission to the company on Falgun 17, 2082 BS. Only after the approval from the regulatory body SEBON, the company can sell shares to the public.
The company has appointed NMB Capital Limited as the issue and sales manager for the IPO.
At present, the company has a paid-up capital of Rs. 128.70 crores. After the IPO (if fully subscribed), the capital will increase to Rs. 171.60 crores.
Sopan Pharmaceuticals Limited is a newly established pharmaceuticals company which formally inaugurated its first ever commercial batch production in the year 2078 BS.
Recommended:
